Immunotherapy and AI Biomarker Advances Might Change The Case For Investing In Roche Holding (SWX:ROG)
In recent developments, Roche has featured prominently in the race to develop TIGIT inhibitors for cancer immunotherapy, while…
Roche Gains CE IVDR Approval for Expanded HER2 Companion Diagnostic
Roche has received CE IVDR approval for two label expansions of its VENTANA HER2 (4B5) Rabbit Monoclonal Primary…
Roche Gains FDA Approval for Expanded HER2 Diagnostic Test Indications
The US Food and Drug Administration (FDA) has approved expanded indications for Roche’s Pathway anti-HER2/neu (4B5) Rabbit Monoclonal…
Roche Receives FDA Nod for Lung Cancer Companion Diagnostic
Summary:The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic to identify MET protein…